跳至主要内容
临床试验/NCT04909424
NCT04909424已完成不适用

Prevalence of Cutaneous Enterococci at Femoral Insertion Site in Transcatheter Aortic Valve Implantation (TAVI)

Clinique Pasteur1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年6月17日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
1
主要终点
Enterococci prevalence

研究概览

简要总结

The general rules of antibiotic prophylaxis in surgery or interventional medicine include the choice of an antibiotic active on the bacteria most frequently encountered in surgical site infections. This antibiotic must cover, the bacteria present on the skin and recognized as responsible for surgical site infections.

The aim of this study is to identify bacteria found in skin flora in the inguinal region of patients undergoing Transcatheter Aortic Valve Implantation (TAVI). Flora found will allow to evaluate the impact of skin preparation and antibiotic prophylaxis protocols as they are currently practiced.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient scheduled for aortic valve replacement by TAVI procedure with trans femoral approach
  • Patient with pre-TAVI assessment performed at Clinique Pasteur
  • Patient affiliated or beneficiary of a social security scheme
  • Patient accepting to participate and having given his no objection

排除标准

  • TAVI procedure by non-trans femoral approach
  • Protected patients: Adults under guardianship or other legal protection; Pregnant or breastfeeding woman; Hospitalized without consent.

结局指标

主要结局

Enterococci prevalence

时间窗: At Day 0 at TAVI intervention time (preoperative)

Proportion of patients with Enterococcus feacalis and other Enterococci in inguinal flora before TAVI

次要结局

  • Skin flora of the groin(At Day 0 at TAVI intervention time (preoperative) after skin disinfection)
  • Infectious events(From day of TAVI to 1 year after intervention)
  • Skin flora of the groin(At Day 0 at TAVI intervention time (preoperative) before skin disinfection)

研究者

申办方类型
Other
责任方
Sponsor
主要研究者

Dr Benoit Fontenel

Principal investigator, MD

Clinique Pasteur

研究点 (1)

Loading locations...

相似试验